Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?

Published:2021-04 Issue: Volume:160 Page:103280
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Torrisi Rosalba,Marrazzo Emilia,Agostinetto Elisa^ORCID,De Sanctis Rita^ORCID,Losurdo Agnese,Masci Giovanna,Tinterri Corrado,Santoro Armando

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference111 articles.

1. Impact of neoadjuvant chemotherapy on nodal disease and nodal surgery by tumor subtype;Al-Hilli;Ann. Surg. Oncol.,2018

2. Immune checkpoint profiles in luminal B breast Cancer;Anurag;JNCI J. Natl. Cancer Inst.,2020

3. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases;Bardou;J. Clin. Oncol.,2003

4. Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy;Bayraktar;Med. Oncol.,2014

5. Bevacizumab added to neoadjuvant chemotherapy for breast cancer;Bear;N. Engl. J. Med.,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pirfenidone inhibits CCL2-mediated Treg chemotaxis induced by palbociclib and fulvestrant in HR+/HER2− breast cancer;International Immunopharmacology;2024-12

2. Peri-Tumoural Lipid Composition and Hypoxia for Early Immune Response to Neoadjuvant Chemotherapy in Breast Cancer;International Journal of Molecular Sciences;2024-08-28

3. Efficacy and safety of different regimens of neoadjuvant therapy in patients with hormone receptor-positive, her2-negative breast cancer: a network meta-analysis;Frontiers in Immunology;2024-08-23

4. Correlation and predictive value of pathological complete response and ultrasound characteristic parameters in neoadjuvant chemotherapy for breast;World Journal of Clinical Cases;2024-08-16

5. Development and validation of a nomogram to predict pathological complete response following neoadjuvant chemotherapy in luminal breast cancer based on clinicopathological features;2024-07-26